Navigation Links
Neurotherapeutics presents special issue on new treatments for Alzheimer's disease
Date:7/24/2008

Chicago, 24 July 2008 The editors of Neurotherapeutics are pleased and proud to announce their July issue, devoted to "Novel Therapeutics for Alzheimer's Disease." Neurotherapeutics (http://www.neurotherapeutics.org/) is the journal of the American Society of Experimental NeuroTherapeutics (ASENT) www.asent.org.

The issue coincides with the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD), being held at McCormick Place, Chicago, July 26 to 31, 2008. Rudolph E. Tanzi, Ph.D., of the Massachusetts General Institute for Neurodegenerative Disease and Massachusetts General Hospital, is a Guest Editor. "In this issue of Neurotherapeutics, we have enlisted several experts in the field to review the most promising new therapeutics currently under development for the treatment and prevention of AD," Dr. Tanzi writes in the introductory editorial.

The eleven papers in the special issue highlight promising therapeutic targets for Alzheimer's disease, providing an update on efforts to develop treatments. Given the central role of amyloid β peptide (Aβ) in the pathogenesis of Alzheimer's disease, cerebral accumulations of Aβ are a major focus. The lead article in the issue looks at techniques for measuring the effects of disease-modifying therapies on cerebral Aβ levelsincluding the key question of whether they correlate with cognitive performance.

Clinical trials aimed at all of these therapeutic targets are underway. In his editorial, Dr. Tanzi expresses "cautious optimism and high hopes" that these trials may lead to new therapeutic approaches to Alzheimer's disease. He concludes, "With several active clinical trials and other promising drugs now headed toward the clinic, the hope is that we will soon have novel AD therapeutics that successfully slow or reverse disease progress in AD."


'/>"/>

Contact: Caroline Foote
c.foote@elsevier.com
215-239-3653
Elsevier
Source:Eurekalert

Related medicine news :

1. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
2. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
3. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
4. ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimers at ICAD 2008
5. OptiNose presents data on highly effective migraine treatment
6. International Association for Dental Research presents awards and fellowships
7. MIKE AND IKE(R) Lemonade Blends(TM) Presents $100,000 to Alexs Lemonade Stand Foundation
8. Journal STEM CELLS Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium
9. The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation
10. Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia
11. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... CA (PRWEB) , ... February 17, 2017 , ... ... that their Chief Executive Officer, George Rogers, was named to Staffing Industry Analysts' ... The Staffing 100 honors those who have made notable contributions to the staffing ...
(Date:2/17/2017)... ... , ... Like most hospitals across the nation, Onslow Memorial Hospital is looking ... Readmission Reduction Program (HRRP), the return of a patient to the hospital within 30 ... While many providers are struggling to leverage limited resources and technology, Onslow Memorial Hospital ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason ... to families and business owners in and around the Hampton Roads metropolitan region, ... prevent all forms of domestic violence. , There are multiple categories of domestic ...
(Date:2/16/2017)... ... February 17, 2017 , ... Harsha Chigurupati knows ... of research, development and clinical trials, the founder of Chigurupati Technologies has invented ... of FDA approved ingredients that when infused into alcohol, protect the consumer’s liver ...
(Date:2/16/2017)... ... 17, 2017 , ... Teaching nursing care of vulnerable children is the focus ... is being created with the support of the Hearst Foundations. An initiative of the ... address what has been identified as a critical gap in preparing the next generation ...
Breaking Medicine News(10 mins):
(Date:2/18/2017)... and Markets has announced the addition of the "Contraceptives - Global ... ... US, Canada , Japan , ... America , and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:2/17/2017)... Feb. 17, 2017  Ethicon, Inc. today announced ... a privately held medical device company that manufactures ... System, a novel minimally invasive device for the ... Medical will enable Ethicon to offer patients a ... Nissen fundoplication surgical procedure. 1 ...
(Date:2/17/2017)... Theravance Biopharma, Inc. (NASDAQ: ... announced the presentation of positive clinical data for ... kinase (JAK) inhibitor designed to be intestinally restricted, ... European Crohn,s and Colitis Organization (ECCO). In a ... its completed Phase 1 study of single-ascending and ...
Breaking Medicine Technology: